0001209191-19-052988.txt : 20191010
0001209191-19-052988.hdr.sgml : 20191010
20191010203229
ACCESSION NUMBER: 0001209191-19-052988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191008
FILED AS OF DATE: 20191010
DATE AS OF CHANGE: 20191010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN JEREMY M
CENTRAL INDEX KEY: 0001256153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 191146919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-08
0
0001636651
Ovid Therapeutics Inc.
OVID
0001256153
LEVIN JEREMY M
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
1
1
1
0
CEO
Common Stock
2019-10-08
4
P
0
60000
2.50
A
4736529
D
Common Stock
35461
I
See Footnote
Common Stock
465116
I
See Footnote
Shares were purchased in a Public Offering of the Issuer at a public offering price of $2.50.
The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse is the manager of Divo. The Reporting Person disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.
The reportable securities are owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein.
/s/ Danielle Mann for Jeremy M. Levin by POA
2019-10-10